Osteoporosis : risk factors, symptoms and management / Alejandro Romero Peña and Virgilio Ortega Perez, editors.

Format:

Book

Contributor:

Peña, Alejandro Romero.

Perez, Virgilio Ortega.

Series:

Endocrinology research and clinical developments.

Aging issues, health and financial alternatives series.

Endocrinology research and clinical developments

Aging issues, health and financial alternatives

Language:

English

Subjects (All):

Osteoporosis.

Physical Description:

1 online resource (191 p.)

Edition:

1st ed.

Place of Publication:

New York : Nova Biomedical, 2012.

Language Note:

English

Summary:

Osteoporosis is a systemic, debilitating disease of the skeleton, characterized by significantly decreased bone mass in combination with the deterioration of bone microarchitecture. This process results in weakened bone with a great propensity for fracture under low-energy stress. This book presents current research in the study of the risk factors, symptoms and management of osteoporosis. Topics include the influence of osteoporosis in oral health; assessment of risk fracture risk and therapeutic effects on osteoporosis; diagnosing future bone fracture; genetic and environmental factors in human osteoporosis; the pathogenesis of skeletal complications in patients with endogenous hypercorticism; genetic and postmenopausal osteoporosis risk; and severely suppressed bone turnover associated with bisphosphonate for osteoporosis. (Imprint: Nova Biomedical)

Contents:

Intro

OSTEOPOROSISRISK FACTORS, SYMPTOMS AND MANAGEMENT

ENDOCRINOLOGY RESEARCH AND CLINICAL DEVELOPMENTS

AGING ISSUES, HEALTH AND FINANCIAL ALTERNATIVES

Library of Congress Cataloging-in-Publication Data

Contents

Preface

CHAPTER 1. The Influence of Osteoporosis in Oral Health

Abstract

Introduction

Methods to Evaluate Osteoporosis Risk Using Panoramic Radiography: Morphometric Indices

Radiological Aspects for Osteoporosis

Evidence Supporting Panoramic Radiography in Screening for Osteoporosis

Evidence against Using Panoramic Radiographs to Screen for Osteoporosis

Diseases Associated with Osteoporosis

Classification of Klemetti

Specific Alterations in the Mandible and in the Maxilla Related with Osteoporosis

Osteoporosis and Periodontitis

Systemic Bone Loss and Dental Implant Treatment

Conclusion

References

CHAPTER 2. Osteoporosis: Risk Factors,Symptoms and Management

Pathophysiology

Classification

Risk Factors

Evaluation of Osteoporosis

BMD Measurement

Laboratory Investigations

Management

Nonpharmacologic Treatment

Pharmacologic Treatment

CHAPTER 3. Management of Osteoporosis: Assessment of Fracture Risk and Therapeutic Effects on Osteoporosis

Management of Osteoporosis

Dual Energy X-Ray Absorptiometry (DXA)

Quantitative Computed Tomography (QCT)

Quantitative Ultrasound (QUS) BoneAssessment Method

Finite Element (FE) Method Based on Data from Computed Tomography (CT/FEM)

Assessment of Vertebral Fracture Risk In Vivo by CT/FEM

Assessment of Alendronate Effects on Osteoporosis In Vivo by CT/FEM

References.

CHAPTER 4. Current Risk Factor Series and the Adequate Track for Diagnosing Future Bone Fracture

Background

Osteoporosis Risk Factors

Lifestyle Factors that Affect Bone Health

Bone Fracture Risk Calculators

DXA Scanning

The Bayes' Theorem

The Finite Element Method

Sensemaking

Future

CHAPTER 5. Genetic and Environmental Factors in Human Osteoporosis

African Women

Sicilian Women

Bone Mass Density Measurement

Statistical Methods

Results

Discussion

CHAPTER 6. Secondary Osteoporosis:Fractures and Bone Remodeling in Patients with Endogenous Hypercortisolism. A Link to the Pathogenesis of Glucocorticoid-Induced Osteoporosis

The Causes and a General Description of Endogenous Hypercortisolism

The Prevalence of Low TraumaticFractures among Patients withEndogenous Hypercortisolism

The Influence of a Mild Disruption of the Cortisol Level on Bone in Patients withAdrenal Incidentaloma

The Restoration of Bone after the Remission of Cushing's Syndrome

Pathogenesis of Glucocorticoid-Induced Osteoporosis

Acknowledgment

CHAPTER 7. Genetic and Postmenopausal Osteoporosis Risk

Genetic Factors and OP

Genetic Polymorphisms in the Estrogen Path and Their Relation with OP

Polymorphisms in ESR1 and ESR2 Genes

Polymorphisms in the FSH Receptor Gene (FSHR)

Polymorphisms of the Aromatase Gene (CYP19A1)

Other Polymorphisms in the Estrogen Pathway

Studies of Genetic Interactions

CHAPTER 8. Severely Suppressed Bone Turnover Associated with Bisphosphonate Therapy for Osteoporosis

Case Report

Severely Suppressed Bone Turnover (SSBT)

Preventing and Treating Severely Suppressed Bone Turnover

Index.

Notes:

Description based upon print version of record.

Includes bibliographical references and index.

Description based on print version record.

ISBN:

1-62081-235-5

OCLC:

841171248